KinDex Therapeutics

Healthcare 📍 Seattle, United States 👥 1-10 employees 💰 $5.5M raised 📅 Founded 2009

The principle targets for KinDex are the regulatory nodes embedded in signaling networks that control genetic expression patterns associated with insulin resistance, Type 2 diabetes, cardio-metabolic syndrome and obesity. KinDex has a portfolio of lead molecules that have demonstrated a novel mechanism of action in the

🌐 Website ← All Companies

📊 Company Overview

Sector

Healthcare

Country

United States

Employees

1-10

Total Raised · Venture

$5.5M

Founded

2009

Cloud

Unknown

CDN

Cloudflare

☁️ Cloud Infrastructure

🔒 Subscribers only Cloud Provider

Behind Cloudflare — actual host undetectable

Workspace	🔒 Subscribers only
CDN	Cloudflare

Detected via DNS records and HTTP response headers as of 2026-06-13.

💰 Estimated Cloud Spend

$18K – $45K / year across cloud providers

🛠 Tech Stack & Marketing

Ad Platforms	🔒 Subscribers only
Analytics & CRM	🔒 Subscribers only
CMS / Platform	🔒 Subscribers only
Frontend Stack	🔒 Subscribers only

Detected from KinDex Therapeutics's public homepage as of 2026-06-13.

🔍 Compare with Similar Companies

Same sector (Healthcare), similar size

1-10 ☁️ Unknown

Central Printing Group

1-10 ☁️ Unknown

Ortho Clinical Diagnostics Holdings Plc

1-10 ☁️ Azure

Data detected 2026-06-13 · Methodology · Suggest a correction